Evaluation of the predisposition of serotonin transporter polymorphisms (5-HTTLPR) and complement factor H (CFH) variants to smoking status

<jats:p xml:lang="tr" />

[1]  Jolanta Chmielowiec,et al.  Association of Polymorphism CHRNA5 and CHRNA3 Gene in People Addicted to Nicotine , 2022, International journal of environmental research and public health.

[2]  Esther de Boer,et al.  Therapeutic Lessons to be Learned From the Role of Complement Regulators as Double-Edged Sword in Health and Disease , 2020, Frontiers in Immunology.

[3]  S. Temel,et al.  Strong Association between Serotonin Transporter 5-HTTVNTR Variant and Psychoactive Substance (Nicotine) Use in the Turkish Cypriot Population. , 2020, Current drug metabolism.

[4]  N. Ngah,et al.  Analysis of the association between CFH Y402H polymorphism and response to intravitreal ranibizumab in patients with neovascular age-related macular degeneration (nAMD). , 2018, Bosnian journal of basic medical sciences.

[5]  N. Volkow,et al.  Neurobiology of addiction: a neurocircuitry analysis. , 2016, The lancet. Psychiatry.

[6]  W. Shin,et al.  Meta-analysis of the association between a serotonin transporter 5-HTTLPR polymorphism and smoking cessation , 2016, Psychiatric genetics.

[7]  D. El-Lebedy,et al.  Complement factor H polymorphism rs1061170 and the effect of cigarette smoking on the risk of lung cancer , 2015, Contemporary oncology.

[8]  P. Chaturvedi,et al.  Harmful effects of nicotine , 2015, Indian Journal of Medical and Paediatric Oncology.

[9]  Imran Ahmad,et al.  Lack of Association between the Serotonin Transporter (5-HTT) and Serotonin Receptor (5-HT2A) Gene Polymorphisms with Smoking Behavior among Malaysian Malays , 2014, Scientia pharmaceutica.

[10]  K. Ghasemi Falavarjani,et al.  Complement Factor H Y402H and LOC387715 A69S Polymorphisms in Association with Age-Related Macular Degeneration in Iran , 2014, Journal of ophthalmic & vision research.

[11]  J. Harro,et al.  Serotonin transporter gene promoter polymorphism (5-HTTLPR) and alcohol use in general population: interaction effect with birth cohort , 2014, Psychopharmacology.

[12]  Y. Mitsumoto,et al.  Effects of moderating factors including serotonin transporter polymorphisms on smoking behavior: a systematic review and meta-analysis update. , 2013, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[13]  M. Fungaro,et al.  Genetic polymorphism of serotonin transporter 5-HTTLPR: involvement in smoking behaviour , 2011, Journal of Genetics.

[14]  Benjamin E. Deverman,et al.  Cytokines and CNS Development , 2009, Neuron.

[15]  L. Boulanger,et al.  Immune Proteins in Brain Development and Synaptic Plasticity , 2009, Neuron.

[16]  Dennis L. Murphy,et al.  How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems , 2008, Neuropharmacology.

[17]  E. Jassem,et al.  Lack of association between serotonin transporter gene polymorphism 5-HTTLPR and smoking among Polish population: a case-control study , 2008, BMC Medical Genetics.

[18]  Na Rae Kim,et al.  Association between complement factor H gene polymorphisms and neovascular age-related macular degeneration in Koreans. , 2008, Investigative ophthalmology & visual science.

[19]  C. Na,et al.  Effect of genetic polymorphisms on smoking cessation: a trial of bupropion in Korean male smokers , 2008, Psychiatric genetics.

[20]  Ching-Yu Cheng,et al.  Association of the Y402H polymorphism in complement factor H gene and neovascular age-related macular degeneration in Chinese patients. , 2006, Investigative ophthalmology & visual science.

[21]  E. Souied,et al.  Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population. , 2005, Molecular vision.

[22]  S. Rodríguez de Córdoba,et al.  The human complement factor H: functional roles, genetic variations and disease associations. , 2004, Molecular immunology.

[23]  R. Tyndale,et al.  Genetics of alcohol and tobacco use in humans , 2003, Annals of medicine.

[24]  W. Slikker,et al.  Fetal and adolescent nicotine administration: effects on CNS serotonergic systems , 2001, Brain Research.

[25]  D. Yurgelun-Todd,et al.  Biological Aspects of the Link between Smoking and Depression , 2000, Harvard review of psychiatry.

[26]  C. Hansch,et al.  The relative toxicity of compounds in mainstream cigarette smoke condensate. , 2000, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[27]  D. Murphy,et al.  Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. , 1998, Molecular pharmacology.

[28]  P. Shields,et al.  The role of the serotonin transporter gene in cigarette smoking. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[29]  K. Lesch,et al.  Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region , 1996, Science.

[30]  C. G. Becker,et al.  Activation of the classical pathway of complement by tobacco glycoprotein (TGP). , 1995, Journal of immunology.

[31]  L. Kozlowski,et al.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. , 1991, British journal of addiction.

[32]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[33]  B. Ghebrehiwet,et al.  Cigarette smoke can activate the alternative pathway of complement in vitro by modifying the third component of complement. , 1985, The Journal of clinical investigation.

[34]  T. Matsuo,et al.  Clinical characteristics and quality of life of smokers at a referral center for smoking cessation. , 2010, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

[35]  Ting-kai Li,et al.  Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents. , 1998, Critical reviews in neurobiology.